<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0796154" disease_type="Disease or Syndrome" abbrv="SDYS">Simpson-Golabi-Behmel syndrome</z:e> (SGBS) is an <z:hpo ids='HP_0001417'>X-linked</z:hpo> syndrome characterized by pre- and postnatal <z:hpo ids='HP_0001548'>overgrowth</z:hpo> (<z:e sem="disease" ids="C0017547" disease_type="Disease or Syndrome" abbrv="">gigantism</z:e>), which clinically resembles the autosomal <z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e> (BWS) </plain></SENT>
<SENT sid="1" pm="."><plain>Deletions and translocations involving the glypican-3 gene ( GPC3 ) have been shown to be associated with SGBS </plain></SENT>
<SENT sid="2" pm="."><plain>Occasionally, these deletions also include the glypican-4 gene ( GPC4 ) </plain></SENT>
<SENT sid="3" pm="."><plain>Glypicans are <z:chebi fb="0" ids="24500">heparan</z:chebi> <z:chebi fb="0" ids="16189">sulfate</z:chebi> <z:chebi fb="0" ids="37396">proteoglycans</z:chebi> which have a role in the control of cell growth and cell division </plain></SENT>
<SENT sid="4" pm="."><plain>We have examined the mutational status of the GPC3 and GPC4 genes in one patient with <z:e sem="disease" ids="C0796113" disease_type="Disease or Syndrome" abbrv="">Perlman syndrome</z:e>, three patients with <z:hpo ids='HP_0001548'>overgrowth</z:hpo> without syndrome diagnosis, ten unrelated SGBS-patients and 11 BWS patients </plain></SENT>
<SENT sid="5" pm="."><plain>We identified one SGBS patient with a deletion of a GPC3 exon </plain></SENT>
<SENT sid="6" pm="."><plain>Six SGBS patients showed point mutations in GPC3 </plain></SENT>
<SENT sid="7" pm="."><plain>One frameshift, three nonsense, and one splice mutation predict a loss-of-function of the glypican-3 protein </plain></SENT>
<SENT sid="8" pm="."><plain>One missense mutation, W296R, changes an amino acid that is conserved in <z:hpo ids='HP_0000001'>all</z:hpo> glypicans identified so far </plain></SENT>
<SENT sid="9" pm="."><plain>A GPC3 protein that reproduces this mutation is poorly processed and fails to increase the cell surface expression of <z:chebi fb="0" ids="24500">heparan</z:chebi> <z:chebi fb="0" ids="16189">sulfate</z:chebi>, suggesting that this missense mutation is also a loss-of-function mutation </plain></SENT>
<SENT sid="10" pm="."><plain>In three SGBS patients and in <z:hpo ids='HP_0000001'>all</z:hpo> non-SGBS patients, no mutations could be identified </plain></SENT>
<SENT sid="11" pm="."><plain>We found three single nucleotide polymorphisms in the GPC4 gene but no evidence for loss-of-function mutations in GPC4 associated with SGBS </plain></SENT>
</text></document>